Advancing Self-Amplifying RNA to Minimise Raw Material Use for Reduced Dosage Needs and Expanded Therapeutic Applications
Time: 9:30 am
day: Day One
Details:
- How can Self-Amplifying RNA’s (saRNA) self-replicating mechanism enable the production of higher protein levels per dose, significantly lowering the initial raw material requirements compared to conventional mRNA?
- How does the prolonged protein expression driven by saRNA elicit robust immune responses with smaller doses for minimising material usage while maintaining therapeutic efficacy?
- How can the scalability and versatility of saRNA support its use across vaccines and therapeutics, reducing the strain on raw material supply chains for broad deployment?
